Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if AGIO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 69 days ago
Red flags: 0
238 filers reported a long position in AGIO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $239.6M | 6.5M | +12.2% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219.6M | 5.9M | +4.1% |
| STATE STREET CORP | $131.1M | 3.5M | +5% |
| Lynx1 Capital Management LP | $126.5M | 3.4M | +30.5% |
| D. E. Shaw & Co., Inc. | $115.3M | 3.1M | +15.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.6M | 2.9M | +11% |
| VANGUARD CAPITAL MANAGEMENT LLC | $99.5M | 2.7M | +1.9% |
| ARMISTICE CAPITAL, LLC | $89.1M | 2.4M | -11.6% |
| Erste Asset Management GmbH | $82M | 2.2M | -20.3% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78.3M | 2.1M | +41.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.